- Home
- Publications
- Publication Search
- Publication Details
Title
Dalbavancin for infective endocarditis: a single centre experience
Authors
Keywords
-
Journal
JOURNAL OF CHEMOTHERAPY
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2020-10-19
DOI
10.1080/1120009x.2020.1823119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Contemporary Picture of Enterococcal Endocarditis
- (2020) Juan M. Pericàs et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Outpatient Parenteral Antibiotic Treatment (OPAT) for Infective Endocarditis: a Prospective Cohort Study From the GAMES Cohort
- (2019) Juan M Pericàs et al. CLINICAL INFECTIOUS DISEASES
- Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population
- (2019) Chloe Bryson-Cahn et al. Open Forum Infectious Diseases
- Multicenter clinical experience of real life Dalbavancin use in gram-positive infections
- (2019) S. Wunsch et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- French national cohort of first use of dalbavancin: a high proportion of off-label use
- (2019) Aurélien Dinh et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Serum bactericidal activity levels monitor to guide intravenous dalbavancin chronic suppressive therapy of inoperable staphylococcal prosthetic valve endocarditis: a case report
- (2019) Martina Spaziante et al. Open Forum Infectious Diseases
- DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
- (2019) Carmen Hidalgo-Tenorio et al. Annals of Clinical Microbiology and Antimicrobials
- Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report
- (2019) Aaron Hakim et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Dalbavancin in the treatment of different gram-positive infections: a real-life experience
- (2018) Emilio Bouza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
- (2018) Kasper Iversen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic
- (2017) Ranjeet Prasad Dash et al. Infectious Diseases
- Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
- (2016) D. Knafl et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- 2015 ESC Guidelines for the management of infective endocarditis
- (2015) Gilbert Habib et al. EUROPEAN HEART JOURNAL
- Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies
- (2015) Michael W Dunne et al. Annals of Clinical Microbiology and Antimicrobials
- Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis
- (2012) S. Leone et al. INFECTION
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century
- (2009) David R. Murdoch ARCHIVES OF INTERNAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started